Feb 13 (Reuters) - Johnson & Johnson JNJ.N:
JOHNSON & JOHNSON STATEMENT ON PHASE 3 E.MBRACE STUDY
J&J: NO SAFETY SIGNALS RELATED TO THE VACCINE WERE IDENTIFIED.
J&J -INDEPENDENT, SCHEDULED REVIEW FINDS INVESTIGATIONAL VACCINE REGIMEN LACKS EFFICACY IN PREVENTING INVASIVE E. COLI DISEASE (IED)
J&J: THE E.MBRACE STUDY IS BEING DISCONTINUED
Further company coverage: JNJ.N